Authors
International Team for the Revision of the International Criteria for Behçet's Disease (ITR‐ICBD), F Davatchi, S Assaad‐Khalil, KT Calamia, JE Crook, B Sadeghi‐Abdollahi, M Schirmer, T Tzellos, CC Zouboulis, M Akhlagi, A Al‐Dalaan, ZS Alekberova, AA Ali, A Altenburg, E Arromdee, M Baltaci, M Bastos, S Benamour, I Ben Ghorbel, A Boyvat, L Carvalho, W Chen, E Ben‐Chetrit, C Chams‐Davatchi, JA Correia, J Crespo, C Dias, Y Dong, F Paixão‐Duarte, K Elmuntaser, AV Elonakov, J Graña Gil, A‐A Haghdoost, RM Hayani, H Houman, AR Isayeva, AR Jamshidi, P Kaklamanis, A Kumar, A Kyrgidis, W Madanat, A Nadji, K Namba, S Ohno, I Olivieri, J Vaz Patto, N Pipitone, MV de Queiroz, F Ramos, C Resende, CM Rosa, C Salvarani, MJ Serra, F Shahram, H Shams, KE Sharquie, M Sliti‐Khanfir, T Tribolet de Abreu, C Vasconcelos, J Vedes, B Wechsler, YK Cheng, Z Zhang, N Ziaei
Publication date
2014/3
Journal
Journal of the european Academy of Dermatology and Venereology
Volume
28
Issue
3
Pages
338-347
Description
Objective
Behçet's disease (BD) is a chronic, relapsing, inflammatory vascular disease with no pathognomonic test. Low sensitivity of the currently applied International Study Group (ISG) clinical diagnostic criteria led to their reassessment.
Methods
An International Team for the Revision of the International Criteria for BD (from 27 countries) submitted data from 2556 clinically diagnosed BD patients and 1163 controls with BD‐mimicking diseases or presenting at least one major BD sign. These were randomly divided into training and validation sets. Logistic regression, ‘leave‐one‐country‐out’ cross‐validation and clinical judgement were employed to develop new International Criteria for BD (ICBD) with the training data. Existing and new criteria were tested for their performance in the validation set.
Results
For the ICBD, ocular lesions, oral aphthosis and genital aphthosis are each assigned 2 points, while skin …
Total citations
2013201420152016201720182019202020212022202320241035515870891039113112314433